Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novus Therapeutics, Inc.

14.60
0.0000
Volume:- -
Turnover:- -
Market Cap:221.34M
PE:-0.65
High:14.60
Open:14.60
Low:14.60
Close:14.60
Loading ...
Dec 04, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 20, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 20, 2020

Major Issues Report

8-K - Current report
Nov 20, 2020

Major Issues Report

8-K/A [Amend] - Current report
Nov 16, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 13, 2020

Correspondence

CORRESP [Cover] - Correspondence
Nov 09, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 14, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Oct 06, 2020

Major Issues Report

8-K - Current report
Oct 05, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Sep 15, 2020

Major Issues Report

8-K - Current report
Sep 04, 2020

Major Issues Report

8-K - Current report
Aug 18, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 14, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 17, 2020

Major Issues Report

8-K - Current report
May 15, 2020

Major Issues Report

8-K - Current report
May 15, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2020

Major Issues Report

8-K - Current report
Apr 23, 2020

Major Issues Report

Current report, item 3.01
Apr 02, 2020

Correspondence

CORRESP [Cover] - Correspondence